2016 -- H 7710 | |
======== | |
LC004903 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2016 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES | |
| |
Introduced By: Representatives Bennett, Hull, McNamara, Azzinaro, and Diaz | |
Date Introduced: February 24, 2016 | |
Referred To: House Corporations | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Chapter 27-18 of the General Laws entitled "Accident and Sickness |
2 | Insurance Policies" is hereby amended by adding thereto the following section: |
3 | 27-18-82. Opioid antagonists. -- (a) Every individual or group health insurance contract, |
4 | plan, or policy that provides prescription coverage that is delivered, issued for delivery, amended |
5 | or renewed in this state on or after January 1, 2017, shall provide coverage for all opioid |
6 | antagonists and all necessary devices and services related thereto, including provision of patient |
7 | information. |
8 | (b) As used in this section: |
9 | (1) "Opioid antagonist" means naloxone hydrochloride and any other drug approved by |
10 | the United States Food and Drug Administration for the treatment of opioid overdose. |
11 | (2) "Patient" has the meaning provided in R.I. Admin. Code 31-2-9:1.0. |
12 | (3) "Patient information" has the meaning provided in R.I. Admin. Code 31-2-9:1.0 |
13 | (c) The coverage mandated by this section shall include all opioid antagonists prescribed |
14 | or dispensed as permitted by R.I. Admin. Code 31-2-9 or any other statute or regulation, |
15 | including, without limitation, opioid antagonists prescribed or dispensed via standing order or |
16 | collaborative practice agreement and opioid antagonists intended for use on patients other than |
17 | the insured. No prior authorization may be required for any opioid antagonist. |
18 | (d) Notwithstanding ยง27-18-19 or any other provision to the contrary, this section shall |
19 | apply to blanket or group polices of insurance. |
| |
1 | SECTION 2. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service |
2 | Corporations" is hereby amended by adding thereto the following section: |
3 | 27-19-73. Opioid antagonists. -- (a) Every individual or group health insurance contract, |
4 | plan, or policy that provides prescription coverage that is delivered, issued for delivery, amended |
5 | or renewed in this state on or after January 1, 2017, shall provide coverage for all opioid |
6 | antagonists and all necessary devices and services related thereto, including provision of patient |
7 | information. |
8 | (b) As used in this section: |
9 | (1) "Opioid antagonist" means naloxone hydrochloride and any other drug approved by |
10 | the United States Food and Drug Administration for the treatment of opioid overdose. |
11 | (2) "Patient" has the meaning provided in R.I. Admin. Code 31-2-9:1.0. |
12 | (3) "Patient information" has the meaning provided in R.I. Admin. Code 31-2-9:1.0 |
13 | (c) The coverage mandated by this section shall include all opioid antagonists prescribed |
14 | or dispensed as permitted by R.I. Admin. Code 31-2-9 or any other statute or regulation, |
15 | including, without limitation, opioid antagonists prescribed or dispensed via standing order or |
16 | collaborative practice agreement and opioid antagonists intended for use on patients other than |
17 | the insured. No prior authorization may be required for any opioid antagonist. |
18 | SECTION 3. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service |
19 | Corporations" is hereby amended by adding thereto the following section: |
20 | 27-20-69. Opioid antagonists. -- (a) Every individual or group health insurance contract, |
21 | plan, or policy that provides prescription coverage that is delivered, issued for delivery, amended |
22 | or renewed in this state on or after January 1, 2017, shall provide coverage for all opioid |
23 | antagonists and all necessary devices and services related thereto, including provision of patient |
24 | information. |
25 | (b) As used in this section: |
26 | (1) "Opioid antagonist" means naloxone hydrochloride and any other drug approved by |
27 | the United States Food and Drug Administration for the treatment of opioid overdose. |
28 | (2) "Patient" has the meaning provided in R.I. Admin. Code 31-2-9:1.0. |
29 | (3) "Patient information" has the meaning provided in R.I. Admin. Code 31-2-9:1.0 |
30 | (c) The coverage mandated by this section shall include all opioid antagonists prescribed |
31 | or dispensed as permitted by R.I. Admin. Code 31-2-9 or any other statute or regulation, |
32 | including, without limitation, opioid antagonists prescribed or dispensed via standing order or |
33 | collaborative practice agreement and opioid antagonists intended for use on patients other than |
34 | the insured. No prior authorization may be required for any opioid antagonist. |
| LC004903 - Page 2 of 4 |
1 | SECTION 4. Chapter 27-41 of the General Laws entitled "Health Maintenance |
2 | Organizations" is hereby amended by adding thereto the following section: |
3 | 27-41-86. Opioid antagonists. -- (a) Every individual or group health insurance contract, |
4 | plan, or policy that provides prescription coverage that is delivered, issued for delivery, amended |
5 | or renewed in this state on or after January 1, 2017, shall provide coverage for all opioid |
6 | antagonists and all necessary devices and services related thereto, including provision of patient |
7 | information. |
8 | (b) As used in this section: |
9 | (1) "Opioid antagonist" means naloxone hydrochloride and any other drug approved by |
10 | the United States Food and Drug Administration for the treatment of opioid overdose. |
11 | (2) "Patient" has the meaning provided in R.I. Admin. Code 31-2-9:1.0. |
12 | (3) "Patient information" has the meaning provided in R.I. Admin. Code 31-2-9:1.0 |
13 | (c) The coverage mandated by this section shall include all opioid antagonists prescribed |
14 | or dispensed as permitted by R.I. Admin. Code 31-2-9 or any other statute or regulation, |
15 | including, without limitation, opioid antagonists prescribed or dispensed via standing order or |
16 | collaborative practice agreement and opioid antagonists intended for use on patients other than |
17 | the insured. No prior authorization may be required for any opioid antagonist. |
18 | SECTION 5. This act shall take effect on January 1, 2017. |
======== | |
LC004903 | |
======== | |
| LC004903 - Page 3 of 4 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES | |
*** | |
1 | This act would require all health insurance providers that provide prescription coverage |
2 | to provide coverage for opioid antagonists (overdose preventive medicine), and all devices and |
3 | services related to the use thereof. This would apply to nonprofit hospital service corporations, |
4 | nonprofit medical service corporations and health maintenance organizations. |
5 | This act would take effect on January 1, 2017. |
======== | |
LC004903 | |
======== | |
| LC004903 - Page 4 of 4 |